Transcenta Holding

Transcenta Holding is a biotech company in China, founded in 2013. It has raised $205.0M across 3 rounds, most recently a $105.0M Venture Round in December 2020.

A Global Fully Integrated Biotherapeutics Company

Employees
201–500
Founded
2013
Business Model
B2B
Total Funding
$205.0M
Last Round
$105.0M Venture RoundDec 2020
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Transcenta is a global, fully integrated biotherapeutics company spanning antibody discovery, translational research, process development, clinical development, and manufacturing. Its antibody generation platform is based on Immune Tolerance Breaking Technology, producing therapeutic candidates with differentiated biological profiles. Translational research generates PK, PD, toxicology, and immunogenicity data to model clinical responses and guide trial design. Clinical development spans centers in Beijing, Shanghai, Guangzhou, and Princeton, US, supported by a flexible modular manufacturing facility using classical fed-batch and perfusion-based continuous bioprocessing.

Summary

It lists 201–500 employees. It has raised $205.0M in total across 3 rounds, most recently a $105.0M Venture Round in Dec 2020. Investors include ARCH Venture Partners, China Structural Reform Fund and Country Garden Venture Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundDec 2020
$105.0M

Sign up to see all 3 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Transcenta Holding on Indexed.vc
<a href="https://indexed.vc/companies/transcenta-holding"><img src="https://indexed.vc/api/badge/company/transcenta-holding" alt="Transcenta Holding on Indexed.vc" width="260" height="76" /></a>